PMID: 42516948

Immune checkpoint inhibitor-driven smooth muscle cell phenotypic modulation: a potential contributor to atherosclerotic risk associated with these therapies.

Chattopadhyay Abhijnan, Dosunmu Aminat O, Reddy Darshan, Dharma Sree, Panchal Krishna, Kwartler Callie S, Milewicz Dianna M

Frontiers in cardiovascular medicine · 2026

Vol. 13, pp. 1789821

View on PubMedDOI

This entry links to third-party literature. For research use only.

For research use only. This index links to third-party literature. Nothing here constitutes medical advice.